The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
November 20th 2024
While a large retrospective study found that interstitial lung abnormalities (ILAs) were evident on 1.7 percent of computed tomography (CT) scans, researchers found that 43.9 percent of ILAs, including fibrotic ILAs, were not reported.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
ADAC builds management as nuclear line picks up
May 6th 1992ADAC Laboratories is riding high on sales of its Genesys SPECTsystems and Pegasys nuclear medicine workstation. The medicalimaging vendor, located in Milpitas, CA, will use this momentumto boost its business outside the U.S. and transfer R&D
Oscar kicks up GE boycott effort
April 8th 1992An industry of protest has grown up around the five-year-old GEboycott over the company's involvement in nuclear weapons production.Infact, the Boston-based support group for the boycott, receivednationwide publicity last month when its film on GE,
Sopha builds support for drive into low-field MRI
January 29th 1992Sopha Medical of Buc, France, has positioned itself to reproducein other medical imaging modalities the targeted R&D and marketingapproach that has proved successful in nuclear medicine, saidDr. Maurice Soustiel, president and CEO. The industrial
ADAC rides multihead nuclear wave
January 29th 1992ADAC Laboratories claimed at the RSNA meeting last month to havegrown from the third-largest supplier of SPECT cameras in theU.S. to first place in 1991. According to ADAC's analysis of theU.S. SPECT market, the top camera suppliers after itself are
GE dedicates dual-head to the heart
January 29th 1992Two different approaches to the nuclear SPECT camera market wereon display at the RSNA meeting last month. There was some debateat the show over the benefits of dedicated versus general-purposenuclear cameras. GE offered a fixed-detector dual-head SPECT
Equipment follows MoAb progress
December 4th 1991With approval of monoclonal antibody-based radiopharmaceuticalsproceeding faster in Europe than in the U.S., market prospectsfor equipment using these targeted nuclear medicine agents arealso more immediate in that region. Care Wise Medical Products of
Philips trims nuclear from portfolio
October 9th 1991Philips Medical Systems has halted manufacture of nuclear medicineimaging systems to concentrate on better business prospects inother modalities. The firm will focus on MRI, ultrasound, CT,x-ray, and radiation therapy, according to Hans van Bree,
Teleradiology firm expands globally
August 28th 1991DataView, a three-year-old teleradiology firm and nuclear medicineremanufacturer based in Tucker, GA, is attempting to build aninternational medical imaging reading and advisory service. The network will focus on China/U.S. communications, accordingto
Multihead SPECT fuels market pep
August 28th 1991Initiation of dual-head single-photon emission computed tomographycamera sales this year will boost revenues in the nuclear marketby about 10%, predicted James L. Besett, general manager of Picker'snuclear medicine division. Unit sales will remain fairly
Trionix builds on Sun relationship
August 14th 1991Nuclear medicine vendor Trionix has always maintained a strongtechnological relationship with Sun Microsystems. Sun computerprocessing technology is built into the firm's high-end triple-and dual-detector SPECT cameras, the Triad and the Biad. The
ADAC shifts to products developed in-house
July 31st 1991ADAC Laboratories hopes to gain market leadership in nuclear medicineby 1994. Coming from a vendor that saw nuclear medicine revenuesslide 30% last year, that spells confidence. Overtaking Siemens,current nuclear leader, represents a major hurdle. To
Elscint uses slip rings to produce 3-D SPECT
July 3rd 1991Dynamic volumetric SPECT acquisition has been made possible throughthe application of slip-ring technology to nuclear medicine. Elscintintroduced Apex Helix, a continuously rotating dual-head camera,at the Society of Nuclear Medicine meeting in
Nuclear develops computer network based on IBM business partnership
July 3rd 1991Summit Nuclear, a unit of Summit World Trade, has formed a businesspartnership with IBM. The IBM RS/6000 workstation serves as thecenterpiece of a nuclear medicine image and information network,called Vision, which was developed internally by Summit.
Cytogen clears major MoAb hurdle in Europe
July 3rd 1991Some observers at the Society of Nuclear Medicine meeting in Cincinnatilast month were hopeful that the first monoclonal antibody imagingagents might receive Food and Drug Administration approval thissummer. Hope is becoming reality more quickly in
Summit uses its own name for nuclear medicine firm
March 13th 1991Summit World Trade changed the name of its nuclear medicine equipmentcompany from Spectrum Medical Systems to Summit Nuclear in January.Summit has also reassigned many of its sales representatives,who had been handling sales for Sopha Medical Systems, to
Elscint pitches patent case at Sopha
February 27th 1991Elscint is readying a nuclear medicine patent infringement suitagainst Sopha Medical of France and its U.S. subsidiary, SophaMedical Systems of Columbia, MD. While Sopha executives are notcertain what specific charges are being made, they maintain